척추수술후증후군 환자에서 경구용 Prostaglandin E1에 의한 치료 경험 -증례보고-

Experience of Administering Oral Prostaglandin E1 for Failed Back Surgery Syndrome -A case report-

  • 이해광 (인제대학교 의과대학 상계백병원 마취통증의학과) ;
  • 우승훈 (인제대학교 의과대학 상계백병원 마취통증의학과) ;
  • 이우용 (인제대학교 의과대학 상계백병원 마취통증의학과)
  • Lee, Hae Kwang (Pain Clinic and Department of Anesthesiology, Sanggye Paik Hospital, College of Medicine, Inje University) ;
  • Woo, Seung Hoon (Pain Clinic and Department of Anesthesiology, Sanggye Paik Hospital, College of Medicine, Inje University) ;
  • Lee, Woo Yong (Pain Clinic and Department of Anesthesiology, Sanggye Paik Hospital, College of Medicine, Inje University)
  • 투고 : 2005.08.16
  • 심사 : 2006.01.23
  • 발행 : 2006.06.30

초록

Oral prostaglandin E1 (PGE1) is a medicine that is clinically applied during a treatment of patients suffering with vascular disease with chronic arterial obstruction because it has vasodilation and anti-platelet effects. The mechanisms of lumbosacral symptoms associated with spinal stenosis probably include vascular insufficiency with hypoxic injury to the cauda equina and the nerve roots. Thus, increasing the blood supply would be beneficial to improve the pathophysiologic condition. Several studies on the improvement of clinical symptoms of spinal stenosis by PGE1 treatment have been reported on. In this case, 47-year old female underwent posterior compression and posterolateral fusion with a cage at L2-4 due to L3 compression fracture, and she did not show improvement of the radiating pain of her right leg after the operation. Therefore, she received repetitive epidural catheterization and adhesiolysis, epidural block and physical therapy, but her symptoms deteriorated after temporary improvement. Finally, she was given PGE1 and the radiculopathy was completely improved, although some muscle weakness still remained.

키워드

참고문헌

  1. Oaklander AL, Richard B: Failed Back Surgery Syndrome. In: Bonica's Management of Pain. 3rd ed. Edited by John D. Loeser: Philadelphia, Lippincott Williams & Wilkins. 2001, pp 1540-7
  2. De La Porte C, Siegfried J: Lumbosacral spinal fibrosis (spinal arachnoiditis): its diagnosis and treatmenr spinal cord stimulation. Spine 1983; 8: 593-603 https://doi.org/10.1097/00007632-198309000-00005
  3. Olmaker K, Rydevik B, Holm S, Bagge U: Effects of experimental graded compression on blood flow in spinal nerve roots. A vital microscopic study on the porcine cauda equina. J Orthop Res 1989; 7: 817-23 https://doi.org/10.1002/jor.1100070607
  4. Ooi Y, Mita F, Satoh Y: Myeloscopic study on lumbar spinal canal stenosis with special reference to intermittent claudication. Spine 1990; 15: 544-9 https://doi.org/10.1097/00007632-199006000-00021
  5. Rydevik B, Brown MD, Lundborg G: Pathoanatomy and Pathophysiology of nerve root compression. Spine 1984; 9: 7-15 https://doi.org/10.1097/00007632-198401000-00004
  6. Evans JG: Neurogenic intermittent claudication. Br Med J 1964; 5415: 985-7
  7. Wilson CB: Significance of the small lumbar spinal canal: cauda equna compression syndromes due to spondylolysis. J Neurosurg 1969; 31: 499-506 https://doi.org/10.3171/jns.1969.31.5.0499
  8. Blau JN, Logue V: The natural history of intermittent claudication of the Cauda equina, a long term follow-up study. Brain 1978; 101: 211-22 https://doi.org/10.1093/brain/101.2.211
  9. Yone K, Sakou T, Kawauchi Y: The effect of Lipo prostaglandin El on cauda eqina blood flow in patients with lumbar spinal canal stenosis: myeloscopic observation. Spinal Cord 1999; 37: 269-74 https://doi.org/10.1038/sj.sc.3100780
  10. Carlson LA, Olsson AG: Intravenous prostaglandinEl in severe peripheral vascular disease. Lancet 1976; 2: 810
  11. Cliford PC, Martin MF, Sheddon EJ, Kirby JD, Baird RN, Dieppe PA: Treatment of vasospastic disease with prostaglandin El. Br Med J 1980; 281: 1031-4 https://doi.org/10.1136/bmj.281.6247.1031
  12. Pardy BJ, Hoare MC, Eastcott HH, Miles CC, Needham TN, Harbourne T, et al: Prostaglandin El in severe Raynaud's phenomenon. Surgery 1982; 92: 953-65
  13. Murakami M, Takashi K, Sekikawa T, Yasuhara K, Yamagata M, Moriya H: Effect of intra- venous lipoprostaglandin El on neurogenic intermittent claudication. J Spinal Disord 1997; 10: 499-504
  14. Nakai K, Takenobu Y, Eguchi K, Takimizu H, Honjo K, Akimaru S, et al: The effects of OP-1206 a-CD on walking dysfunction in the rat neuropathic intermittent claudication model. Anesth Analg 2002; 94: 1537-41 https://doi.org/10.1097/00000539-200206000-00030
  15. T, Sekikawa, Murakama M, Takahashi K, Yasuhara K, Yamagata M, Moriya H: Effect of lipo- prostaglandin El on blood flow and oxygen pressure in lumbo-sacral nerve roots. J Spinal Disord 1997; 2: 289-94